Acrivon Therapeutics, Inc. announced it raised $100 Million in an initial filing from an offering of $100 Million
Acrivon Therapeutics, Inc. announced it raised $100 Million in an initial filing from an offering of $100 Million
11/23/21, 8:56 PM
Location
watertownMoney raised
$100 million
Industry
biopharma
therapeutics
health care
biotechnology
Company Info
Location
480 arsenal way
watertown, south dakota, united states
Additional Info
Acrivon Therapeutics is a clinical stage biopharmaceutical company developing precision oncology medicines. The company utilizes its proprietary proteomics-based patient responder identification platform, Acrivon Predictive Precision Proteomics or AP3, to match patients to specific medicines based on predicted tumor sensitivity.